Showing results (651-660 of 2,961) with videos related to
Sort By:
Pageof 297
Mutation Research|September 10, 1999
A characterization of genetic variants in BRCA1 intron 8 identifies a mutation and a polymorphismM T Pyne, D Pruss, B E Ward, et al.Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|December 4, 2010
The significance of the complement system for the pathogenesis of age-related macular degeneration - current evidence and translation into clinical applicationPeter Charbel Issa, N Victor Chong, Hendrik P N SchollOphthalmology|September 8, 2007
Findings in fluorescein angiography and optical coherence tomography after intravitreal bevacizumab in type 2 idiopathic macular telangiectasiaPeter Charbel Issa, Frank G Holz, Hendrik P N SchollISRN Oncology|November 18, 2011
Pathway profiling and rational trial design for studies in advanced stage cervical carcinoma: a review and a perspectiveSusy M E Scholl, Gemma Kenter, Christian Kurzeder, et al.Zeitschrift Fur Geburtshilfe Und Neonatologie|October 28, 2004
[Conservative treatment of puerperal breast abscesses with repeated sonographically guided aspirations and oral antibiotic administrations]C J Rageth, E S Ricklin, B Scholl, et al.Clinical Pediatrics|July 1, 1989
Growth of abused children. Contrasted with the non-abused in an urban poor communityR J Karp, T O Scholl, E Decker, et al.Gene Expression Patterns : GEP|March 18, 2018
Tracheal expression of Osiris gene family in DrosophilaAaron Scholl, Yuyang Yang, Patrick McBride, et al.Der Ophthalmologe : Zeitschrift Der Deutschen Ophthalmologischen Gesellschaft|July 17, 2008
[Patient reported outcomes. Relevance and application in ophthalmology]R P Finger, H P N Scholl, F G HolzDocumenta Ophthalmologica. Advances in Ophthalmology|August 28, 2009
Metamorphopsia in patients with macular telangiectasia type 2Peter Charbel Issa, Frank G Holz, Hendrik P N SchollRheumatology International|January 26, 2007
Chitotriosidase as a marker of disease activity in sarcoidosisJürgen Brunner, Sabine Scholl-Bürgi, Martina Prelog, et al.Pageof 297